What is BioT Medical?
BioT Medical is pioneering a medical-grade Platform-as-a-Service (PaaS) that introduces a no-code methodology to the highly regulated medical device space. Their solution empowers manufacturers to rapidly deploy medical devices to the cloud via a template-based, drag-and-drop interface, drastically reducing development time, costs, and complexity. The company's Triple-C Connect-Collaborate-Care framework facilitates secure device connectivity to a medical-grade cloud, enhances patient and caregiver engagement, and transforms data into actionable insights for improved clinical decision-making and care experiences.
How much funding has BioT Medical raised?
BioT Medical has raised a total of $6.5M across 1 funding round:
Angel/Seed
$6.5M
Angel/Seed (2021): $6.5M with participation from North First Ventures, XT Hi-Tech, and Bridges Israel
Key Investors in BioT Medical
North First Ventures
North First Ventures is a Venture Capital Fund that partners with seed to round A stage companies in Israel, focusing on innovative technologies that address real-world problems or create new markets. The firm values entrepreneurs who take risks and pursue opportunities that blend innovation with domain expertise.
XT Hi-Tech
XT Venture Capital specializes in providing capital, advice, and support to future category leaders throughout their journey. With over two decades of experience, the firm focuses on making management teams successful by leveraging a broad network, operational expertise, and continuous guidance.
Bridges Israel
Bridges Israel is an impact investment fund that focuses on investing in Israeli businesses to achieve competitive financial returns while also creating significant measurable social and environmental impact. As an independent affiliate of Bridges Fund Management, it aims to support enterprises that contribute positively to society.
What's next for BioT Medical?
The substantial enterprise-level funding indicates BioT Medical is poised for significant scaling and market penetration. This capital injection will likely fuel further development of their no-code platform, expansion into new markets, and strengthening of strategic partnerships within the healthcare technology ecosystem. The company's focus on compliance and ease of use positions it for accelerated adoption by medical device manufacturers seeking to streamline their cloud integration and enhance patient outcomes.
See full BioT Medical company page
